CD36 and fatty liver disease: An early study has identified that RARα overexpression alleviated hepatic steatosis via suppressing HNF4α-regulated PPARγ expression [19], but whether CD36 is involved in RARα’s regulation on hepatic lipid metabolism is unknown.